Stocks in news: Britannia, KIMS, Lupin, Max Finance

 - Sakshi Post

Britannia Ind: Consolidated profit at Rs 555.7 cr, down 40.4% YoY due to high base
Revenue from operations grew 1.4% YoY to Rs 4,256.3 cr during Q3FY24

FSN E-Commerce: Net profit up 106% YoY at Rs 17.5 cr, with revenue increasing 22% to Rs 1,788.8 cr
Gross merchandise value grew 29% YoY

Lupin: USFDA approves abbreviated new drug application for Bromfenac ophthalmic solution
To market generic equivalent of BromSite ophthalmic solution of Sun Pharma in US

Biocon: Gets tentative approval from USFDA for its ANDA for Dasatinib tablets Used in treatment of Philadelphia chromosome positive chronic myeloid leukemia in adults

Kotak Mahindra Bank: CCI approves acquisition of 70% stake in Kotak Mah General Insurance by Zurich Insurance Company

Max Fin: IRDAI approves capital infusion of Rs 1,612 cr by Axis Bank, subject to approval from CCI

Data Infrastructure: Axis Bank sold Rs 932.9 cr worth equity stake in the coAnahere Investment bought 6.06 cr shares at an average price of Rs 154/share

Krishna Institute of Medical Sciences: SBI Life bought 1.4% stake in the company India Advantage Fund S4 I sold 1.3% stake

Results today: Tata Consumer, Power Grid, Nestle India, Lupin, Manappuram Fin, Apollo Tyres, Borosil Renewables, Cummins India, Protean eGov Technologies, Sobha, Trent 


Read More:

Advertisement
Back to Top